12 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
29 Feb 24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
4:16pm
. We are passionate about helping patients in need, and excited about our portfolio, the skilled drug development team we have in place, and the vast
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
is intense, and our future success depends upon our ability to attract, retain and motivate highly-skilled scientific, technical and managerial employees
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
and motivate highly-skilled scientific, technical and managerial employees. We face competition for personnel from other companies, universities, public
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
depends upon our ability to attract, retain and motivate highly-skilled scientific, technical and managerial employees. We face competition
DRS
hqipe5vc
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
ww7i39kx96x8g
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
8pmlje60hi9k14n
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
zgmd5l6cdo1an4
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
k1k6jo9h
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
zhqjwsfr p62i90v5t
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
iu9i4dx2xu5bl6tdh
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next